Occupational fraud rarely announces itself. When a medical practice loses money to internal fraud, the losses accumulate quietly, often for years, before an inconsistency shows up during a staff transition, an audit, or a tax notice. The average practice loss when fraud is finally discovered is materially higher than most owners expect, and the delayed discovery is what makes it so.

Three patterns account for most of the fraud that hits small and mid-sized medical practices: cash-pay and refund manipulation, payroll and ghost-employee schemes, and vendor kickbacks or inflated purchase orders. This piece walks through how each one works, the red flags a physician-owner in Idaho or Utah should learn to spot, and the five internal controls that prevent most of it.

Cash-Pay and Refund Schemes

Cash-pay medicine (fees collected at time of service outside insurance billing) is a real target for asset misappropriation. Staff who handle cash have access to it, and if the practice’s controls do not require reconciliation between service, invoice, and deposit, cash can leave without a trace.

The common patterns:

• Skimming: a portion of a cash payment is pocketed and the encounter is either not recorded or recorded at a lower amount
• Refund manipulation: a refund is issued to a patient who did not request one, and the “refund” is intercepted by the staff member
• Voided transaction schemes: an encounter is entered, the cash collected, then the transaction is voided in the system with no matching cash return

Practices with a growing cosmetic, aesthetic, or membership-medicine cash line face the highest exposure. A cash-line practice with weak controls is one of the easier fraud targets in health care.

Payroll and Ghost-Employee Schemes

Payroll fraud typically works through three variations:

Ghost employees. A fictitious employee is added to the payroll and the paychecks are diverted to an account the perpetrator controls. Works most easily when the person running payroll also has access to add new employees to the system.

Rate or hours manipulation. A real employee’s hours are inflated by the person entering them, or a rate change is entered without proper authorization. Small overpayments compound over months and years.

Unauthorized bonus or reimbursement claims. Expense reimbursements or bonus payments are processed for the perpetrator or a co-conspirator, disguised as ordinary payroll.

The single control that stops most of this is separation of duties: the person who enters payroll should not be the same person who approves the payroll register or reconciles the bank statement.

Vendor Kickbacks and Inflated Purchase Orders

Vendor-side fraud usually involves a staff member with purchasing authority and a vendor willing to participate:

• Kickback arrangements: a vendor pays a portion of each invoice back to the buyer, in cash or gifts
• Shell vendors: a fake vendor is created that bills the practice for services never delivered
• Overbilling: a legitimate vendor bills more than the agreed rate and the buyer approves the inflated invoice
• Inflated purchase orders: quantities or specifications are inflated, and the excess is diverted or resold

Medical supply vendors are the most common vector because most practices have several of them, monthly invoices are common, and no single physician-owner is reviewing every line item.

Red Flags Every Owner Should Watch For

Five patterns show up in most fraud cases well before discovery:

• An employee who refuses to take vacation or refuses cross-training on their tasks
• Vendor payments that consistently round to convenient numbers or come slightly under approval thresholds
• Unusual write-offs, adjustments, or refunds concentrated with one staff member
• Bank reconciliations that consistently require corrections in the same categories
• A rising A/R aging on cash-pay balances while insurance A/R stays clean

Any one of these deserves a conversation. Two or three together deserve a look.

The Five Controls That Prevent Most of It

Internal controls do not need to be elaborate. Five controls, consistently applied, stop the majority of medical-practice fraud:

Separation of duties. No single staff member should have access to cash, the ability to enter or void transactions, and the ability to reconcile the bank statement. Any two of the three is manageable; all three is a control failure.

Daily reconciliation. Cash collected each day should reconcile to encounters recorded that day, before the deposit hits the bank. Reconciling only monthly gives fraud room to hide.

Mandatory vacation coverage. Any staff member handling money should be required to take at least one continuous week off each year, with their duties fully covered by someone else. Most embezzlement schemes require constant attention and cannot survive a week of another person’s eyes on the same records.

Vendor list review. Quarterly review of the active vendor list, with an eye for vendors the owner does not recognize or has not authorized. A fraud vendor rarely survives this review if it happens routinely.

Owner review of monthly bank statements. Not a summary from the bookkeeper. The actual bank statement, checked against the general ledger, with unusual items questioned.

Cooper Norman’s healthcare accounting team reviews internal controls and runs fraud risk assessments for medical practices across Idaho and Utah. To review your current controls before you need to, talk with a Cooper Norman advisor.

Every year, another vendor pitches an Idaho or Utah practice on outsourcing its billing. Every year, another practice considers switching and decides against it, or switches and later regrets it. The reason both experiences are common is that the underlying question is almost always framed as “which is better” when the real question is “at what volume does one beat the other.”

The math is unforgiving. Outsourcing that saves money at one practice loses money at another. In-house billing that works cleanly at one practice hemorrhages cash at another. This piece walks through the real cost stack for in-house billing, how outsourced billing actually prices, the breakeven formula every owner should run, quality signals worth more than price, and the contract terms that matter most.

The Real In-House Cost Stack

The all-in cost of in-house billing includes more than the biller’s salary. The full stack:

• Billing staff salaries plus employer-paid benefits and payroll taxes (typically 20 to 30 percent above base wage)
• Practice management or billing software (license, support, upgrades)
• Clearinghouse fees per claim
• Denial rework time (measured in hours per month at loaded staff cost)
• Physical space and equipment allocated to billing
• Manager time spent supervising billing
• Cost of collection on aged AR that never gets worked

Practices consistently underestimate the last two categories. Manager time and uncollected old AR are the invisible portion of in-house cost, and they can equal or exceed the visible portion.

How Outsourced Billing Actually Prices

Outsourced billing services price in two main structures:

Percentage of collections. Typically 4 to 9 percent of what the vendor collects, with the range depending on specialty, complexity, and volume. Aligned incentives (vendor earns more when they collect more), but the percentage compounds on the practice’s largest revenue category.

Flat fee per claim or per encounter. Predictable cost, but does not scale with claim value or complexity. Sometimes attractive for high-volume, low-value practices.

Hybrid arrangements exist. Some vendors charge a base fee plus a smaller percentage; others charge a percentage of net collections above a floor.

The published rate is not the total cost. Add clearinghouse fees (sometimes included, sometimes not), implementation fees, EHR integration fees, and monthly minimums to build the full comparison.

The Breakeven Formula Every Owner Should Run

The core calculation is straightforward. Add up the true in-house annual cost. Divide by projected annual net collections. Compare that percentage to the vendor’s all-in effective rate. If in-house is materially higher, outsourcing may save money. If materially lower, in-house is more efficient.

Two adjustments matter:

Denial performance. If the vendor’s clean claim rate and denial resolution rate are materially better than the practice’s current numbers, the additional collections change the math. A vendor collecting 3% more of allowed amount can justify a higher percentage fee.

Owner time. If in-house billing consumes several hours of owner or manager attention every week, that time has a value. Reclaiming it for clinical work or growth is a real benefit that does not show up in the direct cost comparison.

Quality Signals Worth More Than Price

Price is the easiest thing to compare and rarely the most important. Four quality signals are worth more:

• Denial resolution turn-around (how quickly denied claims are worked and resubmitted)
• Net collection rate the vendor delivers, not just gross collections
• Client references from practices of similar size and specialty
• Reporting transparency (does the practice see denial reason codes, aging reports, and productivity data, or just monthly summaries)

A cheaper vendor that delivers slower denial resolution and worse net collections is not cheaper. It is a lower headline fee attached to a lower revenue outcome, which is a net loss.

The Contract Terms That Matter Most

Six contract terms deserve careful attention before signing:

• What triggers a fee increase (annual escalators, volume tier changes, service adds)
• Which fees are included and which are pass-through (clearinghouse, integrations, printing)
• Ownership of data at termination (the practice’s claims, payment posting history, and reports)
• Termination notice period and any exit fees
• Business Associate Agreement terms consistent with HIPAA obligations
• Performance guarantees, if any, and what happens when they are missed

Data ownership is the most commonly overlooked. A practice that outsources billing for five years and then decides to switch (or bring back in-house) can find itself facing a large data export fee or a limited-history handoff that damages future collections. This is worth negotiating at signing, not at termination.

Cooper Norman’s healthcare accounting team runs breakeven analyses for practices across Idaho and Utah weighing in-house versus outsourced billing, with real cost stacks and vendor-independent comparisons. To run the numbers on your own practice, talk with a Cooper Norman advisor.

The physicians running solo and small-group practices across Idaho and Utah tend to plan their next patient case in detail and their own exit in vague terms. The two years before a planned retirement are the years most owners start thinking seriously about succession, and by then, most of the useful options have already narrowed.

A five-year runway is not too early. A three-year runway is manageable. A one-year runway usually forces a lower price and a narrower buyer pool than the practice deserves. This piece covers the three realistic succession paths, what should be happening at year five, year three, and year one, the financial cleanup buyers will look for, using an associate hire as a succession strategy, and when a wind-down actually makes more sense than a sale.

The Three Realistic Succession Paths

For solo and small-group practices, three paths cover almost every real transition:

Internal succession to an associate or partner. An existing associate physician, or a new one recruited specifically for succession, buys the practice over time. This is the highest-continuity option and typically the lowest-price option, but it preserves the practice as a going concern and the patient panel it serves.

External sale to a strategic buyer, hospital, or private-equity-backed platform. This produces the highest cash at closing for most practices with adequate scale, at the cost of losing autonomy and often the practice’s independent identity.

Wind-down and patient transfer. The physician retires, transitions patients to other providers in the area, and closes the entity. This is the right path for practices where the value is almost entirely personal goodwill, or where the local market has no buyer.

What Should Happen in Years Five, Three, and One

The five-year mark is the right time to decide which path is realistic. That requires an honest view of the practice’s value, the local buyer market, whether an internal successor exists or can be recruited, and the owner’s own timeline flexibility.

The three-year mark is when the financial cleanup should be well underway. Buyers underwrite the trailing three years of financials in any sale, and expenses that need to be normalized or eliminated need to happen at least three years before the sale closes to sit cleanly in the trailing data.

The one-year mark is when legal documentation, credentialing continuity, contract review, and buyer conversations happen. Trying to compress this into a single year forces trade-offs that cost value.

Financial Cleanup Buyers Will Look For

Buyers, whether internal or external, will look at the same categories of financial cleanliness:

• Owner compensation that reflects a realistic replacement cost, or that can be cleanly adjusted
• Related-party rent at market rates, or disclosed and adjustable
• Personal expenses out of the practice, not run through it
• Revenue cycle metrics (denial rate, DSO, net collection rate) trending stable or improving
• Payer contracts, credentialing, and provider licenses current and organized

Each of these takes time to fix or to season. A physician who cleans up related-party rent three months before a sale is signaling to buyers that the number in front of them may not be reliable. The same cleanup done thirty months before sits inside the trailing period and looks like normal course of business.

Recruiting an Associate as a Succession Strategy

For solo and small-group practices without an internal successor, recruiting one is often the single most valuable succession move. The math is straightforward: a practice with a credible successor already integrated commands a materially higher valuation than one without, and the associate becomes a real buyer at a price both sides can live with.

The recruit should not be the last hire the owner makes. Adding an associate two or three years before retirement gives the associate time to build a book, gives the owner time to see whether the fit is right for succession, and gives the practice time to structure the buy-in on terms both sides negotiated in a calm season rather than a crisis one.

In rural Idaho and Utah, recruiting an associate is often the hardest part of the plan. That is a real reason to start early, not to avoid the path.

When Winding Down Makes More Sense Than Selling

Not every practice has a sale in its future. A wind-down is the right path when:

• The practice’s value is dominated by the personal goodwill of the retiring physician
• The local buyer market is limited to one or two competitors who have not shown interest
• The practice’s revenue is materially below what a buyer would consider worth the diligence effort
• Recruiting an internal successor is not realistic in the available time

A well-run wind-down is not a failure. It preserves the physician’s reputation with patients, delivers care continuity through referrals to trusted local providers, and closes cleanly. Attempting to force a sale on a practice that does not have a viable buyer often produces worse financial outcomes than a planned wind-down would have.

Cooper Norman’s business transition planning team works with solo and small-group medical practices across Idaho and Utah on succession paths from five years out to the year of exit. To evaluate which path is realistic for your practice, talk with a Cooper Norman advisor.

Two federal laws quietly shape almost every financial arrangement a physician practice enters into: Stark Law (the physician self-referral law) and the Anti-Kickback Statute. Between them, they define which financial arrangements are permitted, which require careful structure, and which can create both civil and criminal exposure. A physician-owner in Idaho or Utah does not need to become an expert in either. They do need to know when a proposed arrangement should trigger a call to counsel before the ink dries.

This piece frames the two laws in plain language, describes the fair market value standard that protects most legitimate arrangements, walks through five financial patterns that regularly get practices in trouble, and outlines the documentation every practice should keep on file. It is written from a CPA’s perspective, not a lawyer’s, and it is not legal advice for any specific arrangement.

What Stark Law Actually Prohibits

Stark Law prohibits a physician from referring Medicare or Medicaid patients for specific “designated health services” (DHS) to an entity with which the physician (or an immediate family member) has a financial relationship, unless a specific statutory or regulatory exception applies. DHS categories include clinical laboratory services, imaging, physical and occupational therapy, home health, DME, and several others.

The critical feature of Stark is that it is a strict liability statute. Intent does not matter. If a financial arrangement fits the prohibition and no exception applies, the referral and any resulting Medicare/Medicaid claim are unlawful regardless of whether the physician intended anything improper.

This is why Stark drives so much of how physician financial arrangements are structured. Every arrangement with a referring physician has to either fit an exception or be restructured until it does.

How Anti-Kickback Differs (Intent Matters)

The Anti-Kickback Statute prohibits knowingly and willfully offering, paying, soliciting, or receiving anything of value to induce or reward referrals of federal health-care program business. It applies more broadly than Stark (all federal programs, not just Medicare/Medicaid, and to all types of services, not just DHS).

Unlike Stark, Anti-Kickback requires intent, and violations can carry criminal penalties. The statute is paired with regulatory “safe harbors” that describe specific structures that will not be prosecuted; failing to meet a safe harbor does not automatically mean a violation, but arrangements outside safe harbors are analyzed under the intent standard case by case.

For most practical purposes, arrangements that comply with Stark exceptions and Anti-Kickback safe harbors are on firm ground. Arrangements outside them require careful analysis.

Fair Market Value: The Standard That Protects Almost Everything

Fair market value (FMV) is the recurring standard across most Stark exceptions and Anti-Kickback safe harbors. Compensation, rent, purchase prices, and management fees that are at FMV, commercially reasonable, and not determined based on referral volume generally fit within protective structures.

FMV in health-care regulatory context is not the same as tax FMV. It is the value that would be paid between unrelated parties in an arm’s-length transaction, without any consideration of the parties’ referral relationship. Documenting FMV requires either:

• A written FMV analysis performed by a qualified valuation professional
• Reference to published compensation surveys or market data
• Comparable transactions between unrelated parties in the same market

The documentation is what protects the arrangement in audit or investigation. A physician who “knew it was market” and cannot produce documentation is in a materially weaker position than one who has an FMV memorandum in the file.

Five Financial Arrangements That Get Practices in Trouble

Certain patterns recur in Stark and Anti-Kickback enforcement:

• Rent paid to a referring physician (or from a referring physician) at above-market or below-market rates
• Medical directorships or consulting arrangements paid at rates that are not documented as FMV or where the physician cannot show actual services rendered
• Joint ventures with referring physicians that lack a legitimate business purpose or share profits in a way tied to referral volume
• Free or below-cost items and services provided to referring physicians (staff, space, supplies, EHR licenses)
• Bonus or productivity payments that include referrals to DHS-providing entities within the same group

Each of these can be structured to comply with the law. Each of them, structured casually, has generated significant enforcement.

The Documentation Your Practice Should Keep on File

Compliance documentation is not glamorous but is often what separates a resolved audit from a costly investigation. Every physician arrangement should have:

• A written agreement signed by both parties, dated and current
• FMV documentation appropriate to the arrangement (compensation survey, valuation memo, or comparable data)
• Evidence that services were actually rendered (time logs, deliverables, invoices)
• Board or partnership minutes approving the arrangement
• Annual review confirming continued compliance with the exception or safe harbor being relied on

The absence of any one of these is a weakness. The absence of all five is common in practices that have never worked through a compliance review, and it is worth fixing before it becomes urgent.

Cooper Norman’s healthcare accounting team reviews financial arrangements for compliance documentation and FMV support for medical practices across Idaho and Utah. This overview is general information, not legal or compliance advice. Talk with a Cooper Norman advisor and your health-care attorney about how these rules apply to your specific arrangements. Contact us to review your current file.

Unsolicited offers to buy medical and dental practices are common again, and most of them come from three types of buyers that get abbreviated with three letters. DSO. MSO. PPM. Each one behaves differently, structures deals differently, and produces a different life after close. An owner-doctor in Idaho or Utah who receives one of these letters in the mail deserves to know which type of buyer is on the other end of the conversation before signing an LOI.

The mistake most owners make is treating the three as interchangeable. They are not. This piece walks through the structural differences, how deal consideration usually gets split between cash, rollover equity, and post-close comp, the EBITDA adjustments buyers push during diligence, the tax treatment that actually changes take-home, and what life looks like after the ink dries.

DSO vs. MSO vs. PPM: The Structural Differences

A dental support organization (DSO) is the dental industry’s version of a management services company. In most states, a DSO cannot own the clinical entity outright due to corporate-practice-of-dentistry rules, so it typically buys the practice’s non-clinical assets and enters a management services agreement with the dentist-owned professional entity.

A management services organization (MSO) is the medical equivalent, structured similarly around corporate-practice-of-medicine restrictions. The MSO owns the non-clinical business; the physicians retain the clinical entity and contract with the MSO for management services.

A physician practice management company (PPM) is a broader term for larger, often publicly traded, physician management platforms. Some PPMs are private-equity-backed roll-ups; others are hospital-affiliated. The economics vary.

The abbreviation matters because it shapes what the buyer can and cannot own, how the deal must be structured, and how much post-close autonomy the physician retains over clinical decisions.

How Deal Consideration Is Split (Cash, Rollover, Earnout, Comp)

The headline price is rarely what the seller receives at closing. A typical DSO or MSO deal splits consideration four ways:

• Cash at closing, usually 60 to 80% of the total enterprise value
• Rollover equity in the acquiring platform, held until a future “second bite” liquidity event
• Earnouts tied to post-close performance targets
• Ongoing physician compensation, negotiated as part of the employment agreement

Cash at closing is real money. Rollover equity is a lottery ticket that pays if the platform sells again at a higher multiple, and pays nothing if the platform stalls. Earnouts pay if targets are hit and lose disputes at the moment of measurement. Post-close comp is often the largest single line item over the life of the deal, and it is the number the seller controls least.

EBITDA Adjustments the Buyer Will Push

Buyers do not pay a multiple on the practice’s reported earnings. They pay a multiple on adjusted EBITDA, and the adjustment negotiation is where deal value moves. Common adjustments buyers push during diligence:

• Reducing owner-doctor comp to a market-rate replacement salary (this raises EBITDA and price)
• Backing out one-time expenses (legitimate) and recurring expenses claimed as one-time (contested)
• Normalizing rent to fair market value if the practice pays above-market to a related landlord
• Adding back personal-use expenses run through the practice

The direction of these adjustments is usually favorable to the seller in the aggregate. The seller who does not have a CPA running the adjustment math independently is negotiating without a floor.

The Tax Treatment That Actually Changes Your Take-Home

Federal tax treatment can move the seller’s after-tax take-home by 10 to 20 percentage points depending on how the deal is structured. Three common structures:

An asset sale generally produces ordinary income on depreciation recapture and capital gain on goodwill. It is common in DSO deals because the buyer wants a stepped-up basis and the practice entity is a professional entity that cannot be acquired directly.

A stock or membership interest sale generally produces capital gain to the seller and gives the buyer carryover basis. Simpler tax treatment for the seller; less attractive to the buyer.

An F-reorganization is a specific structure that lets an S corporation seller achieve a mostly capital-gain outcome while still delivering a buyer-friendly asset-purchase structure. It is common in higher-value practice deals and worth understanding in advance.

Life After Close: Autonomy, Culture, and Comp

The physician who sells to a DSO or MSO does not usually stop working the next day. Most deals require a post-close employment or services agreement of three to five years. What that life looks like depends heavily on the acquirer’s operating model.

Two questions worth asking every acquirer during diligence:

• What decisions do the physicians in your existing acquired practices make, and what decisions have moved to corporate?
• How does the compensation model change post-close, and what is the actual take-home difference for the physicians in year three?

Cooper Norman’s healthcare valuation team and transition planning team represent physician-owners across Idaho and Utah in DSO, MSO, and PPM sale conversations, running the EBITDA and tax math before an LOI is signed. To review an offer, talk with a Cooper Norman advisor.

A physician buying $150,000 of new imaging or a dental office replacing four operatory chairs can write off far more in year one than most owners realize. The mechanics come down to two elections: Section 179 and bonus depreciation. Choose the right one and you can front-load six figures of deduction into the year the equipment is placed in service. Choose the wrong one, or fail to plan the timing, and you leave real money on the table.

Both provisions apply to Section 179 medical equipment purchases, but they work differently, have different limits, and interact with state tax rules in ways Idaho and Utah practice owners should not assume are identical to federal. Here is how the two elections stack up in 2026 and how to decide which one fits a given purchase.

What Section 179 Covers for Medical and Dental Practices

Section 179 lets a practice immediately expense the full cost of qualifying tangible property in the year it is placed in service, up to an annual limit. For tax year 2026 the maximum deduction is $2,560,000, and the deduction begins to phase out dollar for dollar once total qualifying purchases exceed $4,090,000. Very few private medical or dental practices hit that ceiling in a single year, which means the practical cap is the business income limitation: Section 179 cannot create or increase a taxable loss.

Qualifying property includes new and used equipment such as imaging units, chairs, sterilizers, digital scanners, ultrasound, lasers, office furniture, computer hardware, and off-the-shelf software. Section 179 also covers certain improvements to nonresidential real property, including HVAC, roofs, security systems, and fire protection, once the building is already in service.

How Bonus Depreciation Works After the OBBBA

Bonus depreciation is a first-year deduction taken on qualified property in addition to any Section 179 election. Under the One Big Beautiful Bill Act signed in July 2025, Congress restored 100 percent bonus depreciation permanently for qualifying property placed in service on or after January 19, 2025. The scheduled 60-40-20 percent phase-down that applied under the TCJA is gone.

Qualified property still generally means tangible property with a recovery period of 20 years or less, along with certain qualified improvement property. Both new and used equipment qualify, provided the practice did not previously use it.

Because bonus depreciation is not limited by the Section 179 annual cap, and because it can create or increase a net operating loss, it becomes the workhorse for larger single-year purchases or for practices with modest current-year income.

Section 179 vs. Bonus Depreciation: Which Election Wins When

The decision comes down to three factors: total qualifying purchases, current-year taxable income, and how each state treats the deduction.

Use Section 179 when you want line-item control. A practice can pick which specific assets to expense and elect only part of the cost, spreading the rest over regular depreciation. That flexibility matters when a practice owner is managing income around the QBI phase-in range, an S-corp shareholder wage base, or a partnership special allocation.

Use bonus depreciation when the purchase is large enough to bump against the Section 179 business-income limit, when the practice expects to run a net operating loss, or when a physician-owner is planning to acquire equipment through a partnership and needs a partner-level deduction that flows regardless of practice-level income.

Practices often use both. A $500,000 equipment year might see $250,000 elected under Section 179 to manage the shareholder wage base, with the balance taken as 100 percent bonus depreciation on the remaining assets.

Idaho and Utah State Conformity

Federal is only half the picture. Idaho conforms to the Internal Revenue Code as of a fixed date and revisits that conformity each legislative session. Utah tracks the federal treatment of Section 179 and bonus depreciation reasonably closely but has historically decoupled in specific years. A deduction that saves a physician forty percent federally may recover only part of that on the state return depending on which conformity update is in force.

Before you sign a purchase order, confirm the current state conformity status for the year the property will be placed in service. The state math often changes the ranking between the two elections.

Common Mistakes When Writing Off Medical Equipment

Three mistakes come up more than any other. First, placing property “in service” is the trigger, not signing the invoice or taking delivery. A CBCT unit sitting in a crate until January produces no year-one deduction for the prior year. Second, listed property such as vehicles used for practice errands carries stricter substantiation rules and lower luxury caps. Third, Section 179 recapture applies if business use drops below 50 percent, which occasionally catches owners who lease equipment out to another entity.

The right answer for a specific purchase depends on the practice’s entity type, the shareholder-wage strategy, projected taxable income, and whether Idaho or Utah is the state return. Run the numbers with a CPA before you sign. Our team at Cooper Norman advises medical and dental practice owners across Idaho and Utah on practice tax planning, and equipment timing is one of the highest-leverage conversations we have.

This overview is general information, not tax advice for your specific situation.

RVU-based compensation is now the dominant model for employed physicians and a common structure inside physician-owned groups too. It ties pay to production, and on the surface, that sounds like a fair alignment: work more, earn more. Underneath, the model has enough moving parts that a physician can sign a contract that looks good on the top line and produces less take-home than a straightforward salary would.

For physicians in Idaho or Utah looking at a new employment offer or considering how to structure a partner comp arrangement in a small group, understanding what RVUs actually measure and how they convert into pay is essential. This walk-through covers the anatomy of an RVU, how conversion factors work, the tradeoff between base and pure RVU structures, and the scenarios worth modeling before signing.

What an RVU Is (and Why wRVU Is the Number That Pays)

A relative value unit, or RVU, is Medicare’s measure of the resources it takes to deliver a service. Each CPT code has an RVU value published in the Medicare Physician Fee Schedule, and the total RVU for a code is the sum of three components: work RVU (physician time and effort), practice expense RVU (overhead), and malpractice RVU (professional liability).

Compensation almost always ties to work RVU (wRVU), not total RVU. That distinction matters because the wRVU component is smaller than the total, and it is the physician’s own effort the practice is paying for. If a contract quotes a “conversion factor per RVU” without specifying wRVU, ask which one. The dollar-per-RVU numbers look very different depending on which base you use.

How a Practice Converts wRVU to Physician Pay

The conversion factor is the dollar amount paid per wRVU produced. It varies significantly by specialty, geography, employer type, and negotiating leverage. Primary care conversion factors are lower than surgical specialty conversion factors, and academic centers usually pay differently than hospital-employed models, which usually pay differently than physician-owned groups.

The math is simple. A cardiologist producing 9,000 wRVUs a year at a $65 per wRVU conversion factor earns $585,000 in production comp. That same physician at $55 earns $495,000. The difference is not clinical performance; it is what the contract says. Confirming the current conversion factor for the specialty, market, and employer type is the single highest-leverage step before negotiating.

Base + RVU vs Pure RVU: When Each Works

Compensation structures fall on a spectrum from pure salary to pure RVU. Most contracts sit somewhere in between: a guaranteed base plus a per-RVU rate above a production threshold, sometimes with a stop-loss floor.

Base plus RVU works for physicians in ramping situations, new grads, or specialties where volume is not entirely in the physician’s control. The base cushions slow months. A pure RVU structure works when a physician is established, has stable referral flow, and wants full upside on effort. For a rural Idaho practice where referral patterns take years to build, a pure RVU offer to a new hire is often not a fair structure regardless of the conversion factor.

The Downside Scenarios a Physician Should Model First

Every physician looking at an RVU comp offer should model at least three scenarios before signing:

• A 15% drop in wRVU production (illness, family leave, market slowdown, a payer network change)
• An unfavorable schedule change (fewer OR days, added call coverage, reduced clinic capacity)
• A conversion factor reset (some contracts allow the employer to adjust the factor annually)

The best-case scenario always looks good. The average-case and worst-case scenarios are where contracts get accepted or renegotiated. If the worst-case take-home is materially below what a straight salary would pay, the physician is bearing risk without adequate compensation for it.

What to Ask Before Signing an RVU Contract

Six questions matter more than the headline number:

• Is the conversion factor tied to work RVU only, or total RVU?
• Is the conversion factor fixed, or does the employer reset it annually?
• Is there a production threshold before RVU kicks in, and if so, is the threshold reasonable for the specialty?
• How are non-billable services (call, admin, teaching) credited?
• Is there a stop-loss or minimum guarantee?
• What happens to accrued but unpaid RVU credits if the physician leaves mid-year?

Contracts that answer all six clearly are usually fair. Contracts that leave two or three ambiguous almost always resolve in the employer’s favor at the moment of dispute.

RVU-based pay is not inherently good or bad; it is a structure that rewards specific patterns of work. For a physician-owner running a group, it can align partner comp with production without penalizing the newer physician still building volume. For a physician considering an employed position, the details determine whether the model pays fairly or transfers risk without transferring reward.

Cooper Norman’s healthcare accounting team models RVU comp offers for physicians across Idaho and Utah and reviews partner-comp structures in physician-owned groups. Before signing a new contract or restructuring one, talk with a Cooper Norman advisor about running the scenarios on paper first.

Every practice P&L looks the same at first glance: revenue on top, expenses below, net income at the bottom. What separates a healthy practice from one drifting into trouble is not the format of the P&L; it is the ratios inside it. A 60% overhead ratio looks alarming in a dermatology practice and looks normal in a primary care office. Reading a medical P&L means reading it against the right specialty benchmark, not against a generic small-business standard.

For a physician-owner in Idaho Falls, Twin Falls, or Provo, learning to read the P&L quickly each month is one of the highest-leverage skills there is. This piece covers the six ratios that matter most, how they differ by specialty, why trend beats snapshot, and the warning signs worth acting on before the year closes.

The Six Ratios That Matter Most on a Practice P&L

Six ratios do most of the work of reading a medical P&L:

• Provider compensation as a percentage of net collections
• Non-provider staff payroll as a percentage of net collections
• Occupancy (rent, utilities, common area) as a percentage of net collections
• Medical supplies as a percentage of net collections
• Total overhead (everything except provider comp) as a percentage of net collections
• Net operating income before physician distributions as a percentage of net collections

Every specialty has a range for each. The point is not to hit an exact number; it is to know when a ratio has drifted materially outside its normal range for the specialty and to understand why before the drift becomes structural.

How Overhead Differs by Specialty

Overhead percentage is the single most misread number on a medical P&L. General surgery and orthopedics typically run lower overhead because their per-visit revenue is high. Primary care and pediatrics run higher overhead because their per-visit revenue is lower and staff-intensive workflows are the same either way.

Dermatology and dentistry sit differently again, with higher supplies and equipment ratios but often lower staff ratios. Comparing a primary care practice’s overhead percentage to a dermatology benchmark is not useful; comparing it to peer primary care practices is.

Provider Compensation as a Percentage of Revenue

Provider comp is a management ratio, not a cost ratio. What matters is not whether the number is high, but whether the practice is producing the revenue to support it. A provider comp percentage rising while collections are flat is one of the earliest signs that the compensation model has drifted out of alignment with production.

In a physician-owner practice, this number includes the owner’s own take. Reading it monthly forces a conversation about what the practice is actually leaving to reinvest, and whether the current pace of distributions is sustainable through a slow quarter.

Reading Trend, Not Snapshot

A single month’s P&L is noise. Vacations, seasonal patient patterns, and payer timing all move the numbers around. Trend is signal.

The most useful view is a rolling three-month average of each key ratio, laid alongside the same period twelve months prior. A ratio moving 1 to 2 percentage points month over month is normal. A ratio moving 3 to 5 percentage points over a rolling three-month window is a real change and worth an owner conversation.

Practices that read the P&L this way catch drift while there is time to respond. Practices that only look at the annual number see the drift after it has already compounded.

The Warning Signs to Act on This Quarter

Four patterns show up on a P&L before they show up in cash:

Staff payroll rising as a percentage of collections without a corresponding rise in patient volume usually means either wage inflation the practice absorbed without adjusting prices or fee schedules, or an FTE creep that snuck up over a few hires.

Medical supplies rising faster than revenue often means either genuine cost inflation from vendors or a workflow change that shifted the mix toward higher-supply procedures. Both deserve a look.

Occupancy rising as a percentage of revenue is almost always a revenue problem, not a rent problem. Rent is fixed; the ratio moves because the numerator moved.

Net operating income compression without a specific line item cause usually means a slow drift across three or four accounts, none large enough to notice individually. That is the version worth the closest look, because the fix is workflow rather than a single vendor renegotiation.

Cooper Norman’s healthcare accounting team builds monthly practice P&L reviews for physician-owned groups across Idaho and Utah, with specialty-appropriate benchmarks and trend analysis. To have your own P&L read against the right benchmarks, talk with a Cooper Norman advisor.

The Section 41 research credit is not just for pharmaceutical companies and semiconductor plants. A dental lab designing custom prosthetics, an oral surgery practice refining a novel implant workflow, or a group practice developing a custom EHR integration can all qualify for the R&D tax credit medical practice owners often assume is out of reach. The four-part test in the tax code does not mention lab coats or clean rooms. It rewards technical work aimed at eliminating uncertainty, and clinical practices produce that kind of work more often than they realize.

The credit became more valuable in 2025. Under the One Big Beautiful Bill Act, immediate deductibility of domestic research expenses was restored, reversing the five-year amortization that had made §174 a headache since 2022. For medical and dental practices with even modest R&D activity, the combined effect of the credit plus immediate deduction is meaningful.

The Four-Part Test in Plain Language

Section 41 defines qualified research using four requirements. All four must be met.

First, the activity must have a permitted purpose, meaning it aims to develop or improve a product, process, technique, formula, invention, or software used in the taxpayer’s business. In a clinical setting, that includes a new diagnostic protocol, a modified surgical technique, or software that connects two clinical systems.

Second, the activity must be technological in nature. It has to rely on principles from the physical, biological, engineering, or computer sciences. Medicine and dentistry are biological and physical sciences, so most clinical technical work satisfies this element.

Third, the activity must aim to eliminate technical uncertainty. The physician or the lab must not know at the outset whether the approach will work or which of several approaches is best. Uncertainty is the core of the credit and the element most often missing on the practice side.

Fourth, the activity must proceed through a process of experimentation. That means evaluating alternatives, testing hypotheses, and iterating based on results. It does not have to look like a formal clinical trial.

What Actually Qualifies Inside a Medical or Dental Practice

The credit is broader than most practice owners assume. Qualifying activities in the clinical world commonly include:

• Custom prosthetic and orthotic design in a dental or oral surgery lab, where each case involves iterative fit and function work.
• Development or substantial modification of surgical instruments, guides, or splints.
• Novel treatment protocols that combine existing modalities in new ways, provided the outcome is uncertain and the process is documented.
• Custom software development, including EHR integrations, patient portals, and analytics tools built in-house.
• Process improvements in imaging or lab workflows that use technical principles and aim to improve accuracy, speed, or safety.

Activities that generally do not qualify include routine patient care, ordinary quality improvement, market research, and adopting a vendor’s product as delivered without technical modification.

§174 Under OBBBA: Immediate Deduction Restored

From 2022 through 2024, §174 required domestic research expenses to be amortized over five years rather than deducted currently. That rule reduced the effective benefit of a research effort in the year the work happened and pushed some practices to stop counting R&D activity entirely.

The One Big Beautiful Bill Act reversed that treatment. Domestic research expenses paid or incurred in tax years beginning after December 31, 2024 are immediately deductible again. Foreign research expenses remain on a 15-year amortization schedule. Retroactive relief is also available for domestic R&D investments made between 2022 and 2024, which means some practices can accelerate or amortize those prior-year costs on an amended return or under an elective method.

The interaction with the §41 credit is favorable. Immediate deduction plus the credit means the after-tax cost of qualifying research is meaningfully lower than it was through 2024.

The Payroll Offset for Newer Practices

Practices with less than $5 million in gross receipts and no gross receipts before the past five years can elect to apply up to $500,000 of the research credit against payroll tax rather than income tax. The payroll offset was doubled from $250,000 to $500,000 under the Inflation Reduction Act, and it is the most useful feature of the credit for a young practice that is not yet profitable.

A new dental practice that spent $200,000 on qualifying research activity in its second year of operations could generate a credit in the tens of thousands and apply it against the employer portion of payroll tax on the next several quarterly filings, effectively getting cash back before the practice ever owes federal income tax.

Documentation You Need Before You Claim

The credit requires contemporaneous evidence. That means dated project notes, iteration logs, cost tracking by project, employee time allocated by activity, and a written statement of the technical uncertainty being addressed. Practices that treat R&D activities as ad hoc and undocumented tend to fail on examination even when the work would have qualified.

Cooper Norman advises medical and dental practice owners in Idaho and Utah on practice tax planning, and we have credited the same activities on the manufacturing and construction side for years, including in our earlier post on the R&D credit for construction businesses. If your practice runs a dental lab, develops software in-house, or works on protocols where the outcome is not known in advance, the credit is worth a serious look.

This overview is general information, not tax advice for your specific situation.

A medical practice can be fully booked and still leave money on the table. The revenue cycle, from patient registration to final payment, is where profitability lives or dies, and most practice owners look at a fraction of the metrics that would tell them what is happening. A monthly review of the right five KPIs takes about fifteen minutes and catches most problems before they compound.

The list below is not exhaustive. It is the five KPIs a physician-owner in Idaho Falls, Twin Falls, or Provo can actually watch each month, understand quickly, and act on. Each one measures a different point in the cycle, and each has a specific fix when the number goes the wrong direction.

Clean Claim Rate: The First Signal of Front-End Health

The clean claim rate is the percentage of claims that pass the payer’s edits on the first submission, without rejection or manual rework. It is a direct reflection of front-office work: eligibility verification, correct patient demographics, current insurance, valid authorizations, and clean coding.

When the clean claim rate slips, the cause is almost always upstream of billing. Rework is expensive, and every rework claim slides into the aging bucket. Practices that push their clean claim rate up by fixing registration workflow generally see downstream metrics improve at the same time, because the same errors that cause claim rejection also cause denials.

Denial Rate: What Percentage Comes Back the First Time

Denial rate is the percentage of submitted claims returned unpaid, broken out by reason. Watching the aggregate denial rate is useful; watching it by reason code is where the money is. A rising denial rate driven by prior authorization is a very different problem than a rising rate driven by medical necessity.

The three questions a denial report should answer each month are: which payer is driving the increase, which reason code is behind it, and what is the working queue age on the affected claims. If any denial is sitting past sixty days without action, the practice is training its billers that denials do not need to be worked promptly, and that habit is hard to break once it sets in.

Net Collection Rate: The Number That Actually Pays the Bills

Net collection rate is total collections divided by allowed amount (charges after contractual adjustments). It measures how much of the money the practice is actually owed under its contracts is being collected. A net collection rate under 95% means real money is being written off, appealed poorly, or missed at the patient-responsibility stage.

The gap between 95% and 100% is the collectible money the practice is losing. On a practice with $2 million in net collections, that gap can be six figures a year. Practices rarely fix this by working harder on the same workflow; the improvement usually comes from a specific change to patient-responsibility collection at time of service, or a change to how denials over 45 days are triaged.

AR Aging: Where Your Money Is Stuck

AR aging shows the practice’s receivables broken into buckets: current, 31 to 60 days, 61 to 90 days, 91 to 120 days, and over 120 days. The number to watch is the percentage of AR sitting past 90 days. Anything over 15% in that bucket is a warning sign; over 25% is a problem that will not fix itself.

Aging concentrates the practice’s worst work. Old AR is old because someone did not follow up, a denial did not get resolved, or a patient balance was not pursued. A monthly aging review with an owner for each account over 90 days closes more claims than any process change.

Cost to Collect: The Metric Almost No One Runs

Cost to collect is total revenue cycle expense (billing staff, clearinghouse fees, outsourced billing, software) divided by net collections. It answers a question few practice owners ask: how much of every dollar we collect goes to the collecting itself?

Industry ranges vary by practice size and specialty, and the number matters less than the trend. A cost to collect that rises quarter over quarter while collections stay flat means the revenue cycle is getting more expensive to run without producing more cash. That is the moment to look hard at whether the current workflow, headcount, or vendor mix is still right for the practice.

These five KPIs are not the only metrics worth watching, but they are the ones that separate a busy practice from a profitable one. Cooper Norman’s healthcare accounting team builds monthly revenue cycle dashboards for practices across Idaho and Utah, and connects the metrics to the cash-flow forecast and owner-comp math. To review your own revenue cycle numbers, talk with a Cooper Norman advisor.